Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 02/23/17 → 11/28/23 |
Funding
- Gilead Sciences Incorporated: $197,885.00
IIS: Use of Novel Biomarkers to Assess Early Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines
- Baer, Lea (CoPI)
- Skopicki, Hal A (CoPI)
- Bloom, Michelle (PI)
- Papadimitriou, Lampros (CoPI)
Project: Research